IL17A and Myocardial fibrosis: Interleukin-17 (IL-17) is a more specific pro-inflammatory cytokine that belongs to a new family of cytokines with no homology to other known interleukins, which are expressed in immune or non-immune cells (143), with IL-17A playing a key role in both myocardial inflammation and myocardial fibrosis.